New Era Requires New Approach to Drug Approvals
dc.creator | Brooks, Steve | |
dc.date.accessioned | 2022-04-18T17:58:00Z | |
dc.date.available | 2022-04-18T17:58:00Z | |
dc.date.issued | 2020-06-19 | |
dc.description | With a coming flood of new drugs to fight COVID-19, a study suggests innovative ways for the FDA to speed up the approval process. | |
dc.description | Based on the research of Francisco Polidoro Jr. | |
dc.description.department | Management | |
dc.identifier.uri | https://hdl.handle.net/2152/111759 | |
dc.identifier.uri | http://dx.doi.org/10.26153/tsw/38664 | |
dc.language.iso | eng | |
dc.relation.ispartof | Big Ideas | |
dc.relation.ispartof | Big Ideas | |
dc.rights.restriction | Open | |
dc.rights.restriction | Open | |
dc.source.uri | https://medium.com/texas-mccombs/new-era-requires-new-approach-to-drug-approvals-b814eae9418 | |
dc.subject | Innovation | |
dc.subject | Health Care | |
dc.subject | Francisco Polidoro Jr. | |
dc.subject | drugs | |
dc.title | New Era Requires New Approach to Drug Approvals | |
dc.type | Blog | |
dc.type | Article |